Tuesday, August 4, 2026

Seoul Asan Team Performs Asia-Pacific’s First Robotic Supermicrosurgery Connecting Submillimeter Vessels

South Korean researchers successfully connected ultrafine blood vessels using a supermicrosurgery robot, enhancing reconstructive surgery techniques.

US Senate Passes NDAA Limiting USFK Reduction, Trump Signature Pending

The U.S. Senate passed the NDAA for FY2026, limiting troop reductions in South Korea and allocating $901 billion for defense.

That Email from Google?—Google DKIM Flaw Enables Dangerous Replay Phishing Scam

A phishing scheme exploiting Google's email vulnerabilities is rising, using deceptive emails to trick users and bypass security measures.

Tag: licensing

Pharos iBio Targets Global Licensing Deals, Expands U.S. and European Market Strategy

Pharos iBio aims to secure licensing deals and enhance its AI drug discovery platform for rare diseases, targeting global partnerships.

K-Bio shifts focus to clinical data as key trial readouts stack up in second half

Korea's biotech sector shifts focus to clinical data in H2 2023, with key results from leading companies expected to drive investor sentiment.

Alteogen CEO Says Additional Licensing Deals Near Completion, Highlights Patent Strength [BIO USA]

Alteogen is nearing global licensing deals, focusing on maximizing value and expanding its platform technology in biopharma.

AI Kidney: Revolutionizing Kidney Disease Prediction with U.S. Market Launch

Rokit Healthcare has completed certification for its AI kidney disease prediction solution, 'AI Kidney,' for the U.S. market.

Top News

- Our Sponsors Ad -

Follow us